| Details |
title |
year |
| Details |
W1. HLD200, A NOVEL DELIVERY SYSTEM OF METHYLPHENIDATE, IN CHILDREN WITH ... |
2016 |
| Details |
W2. CENTANAFADINE SR (CTN-SR) DEMONSTRATES BRAIN OCCUPANCY AT NOREPINEPHR... |
2016 |
| Details |
W3. DASOTRALINE: A NOVEL DRUG CANDIDATE BEING EVALUATED FOR THE TREATMENT... |
2016 |
| Details |
W4. A RANDOMIZED PLACEBO-CONTROLLED MULTICENTER TRIAL OF A LOW-DOSE BEDTI... |
2016 |
| Details |
W5. AN OPEN LABEL PILOT STUDY OF ADJUNCTIVE ASENAPINE FOR THE TREATMENT O... |
2016 |
| Details |
W6. LURASIDONE IN THE TREATMENT OF BIPOLAR DEPRESSION: EFFECT OF BASELINE... |
2016 |
| Details |
W7. A RETROSPECTIVE STUDY OF TRANSCRANIAL MAGNETIC STIMULATION (TMS) IN T... |
2016 |
| Details |
W8. DISCREPANCY BETWEEN SUBJECTIVE AND OBJECTIVE SLEEP PARAMETERS IN SYMP... |
2016 |
| Details |
W9. TREATING PEDIATRIC ANXIETY: THE USE OF SSRIS AND OTHER PRESCRIPTION M... |
2016 |
| Details |
W10. VIRGIL INVESTIGATIVE STUDY PLATFORM: IMPROVING SIGNAL DETECTION IN P... |
2016 |
| Details |
W11. ACCESS TO INFORMATION ON SCHIZOPHRENIA PATIENTS MEDICATION ADHERENC... |
2016 |
| Details |
W12. THE ECOA AND PAPER REVISED NEGATIVE SYMPTOM ASSESSMENT- 16 (NSA-16) I... |
2016 |
| Details |
W13. A RETROSPECTIVE ANALYSIS OF THE EFFECTS OF SUBJECT CHARACTERISTICS O... |
2016 |
| Details |
W14. REDUCED INHIBITORY CONTROL MEDIATES THE RELATIONSHIP BETWEEN CORTICA... |
2016 |
| Details |
W15. ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND DEPRESSION: SEQUENTIAL ... |
2016 |
| Details |
W16. IMPROVING ALZHEIMER'S DISEASE DATA QUALITY THROUGH VIDEO MONITORING... |
2016 |
| Details |
W18. CATEGORICAL IMPROVEMENTS IN DISEASE SEVERITY IN MDD PATIENTS TREATED... |
2016 |
| Details |
FROM POST-HOC ANALYSES OF TWO PIVOTAL STUDIES... |
2016 |
| Details |
W21. A POST HOC SUBGROUP ANALYSIS OF THE IMPACT OF VORTIOXETINE ON FUNCTI... |
2016 |
| Details |
W22. PERSEVERE: A STUDY OF ESKETAMINE FOR THE RAPID REDUCTION OF THE SYMP... |
2016 |